Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Ovarian Neoplasms 3Breast Neoplasms 3Polycythemia Vera 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thymic aplasia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Severe Combined Immunodeficiency 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Dysautonomias 1Polycystic Ovary Syndrome 1Neuroblastoma 1Neoplasms 1Mucopolysaccharidosis I 1Metabolic Syndrome 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Insulin Resistance 1Immunologic Deficiency Syndromes 1Hyperandrogenism 1Hodgkin Disease 1Hematologic Neoplasms 1

Interventions

Prospective Studies 1Phlebotomy 1Paclitaxel 1Follow-Up Studies 1Combined Modality Therapy 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Cancer Vaccines 1Biological Specimen Banks 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mucopolysaccharidosis I × Phlebotomy × Clear all
NCT00695279 2024-10-30

Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

St. Jude Children's Research Hospital

Completed
41 enrolled
CNSOther hematologic neoplasm

Mucopolysaccharidosis I, Neoplasms, Neuroblastoma, Severe Combined Immunodeficiency, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡